World Bio-Informatics Market (2005-2010) - Market Research Reports

Printer Friendly

Printed from http://www.researchandmarkets.com/reports/310170

World Bio-Informatics Market (2005-2010)

Description:

In the recent years, the continuously changing market of bioinformatics applications enjoys a wide acceptance owing to declining new drugs’ manufacturing, non-existence of potential drugs and expiry of patents. In 2004-05, this market with a US $1.4 billion has been competing with unusual and innovative tools facilitating critical R&D for the bioinformatics companies.

“World Bio-Informatics Market (2005-2010)” gives the latest information on new products and trends in the bioinformatics industry as also research, product development and investment pertaining to the market segments.

As it stands the bioinformatics market is at stability where 20% of the applications discovered are based on genomics and proteomics, which boosts growth of bioinformatics tools. A greater number of R&D centers across the world are seeking a common base for transfer of data, information and knowledge to enable an informatics-based decision support system. The market research report forecasts the bioinformatics market to provide an information processing system, assimilation of past developments and scope in future.

Our analysts predict the product lines, software tools and other biometric applications to project an annual market growth of 15.8% or US $3 billion by 2010 higher by 14.5% in 2003. With this the bioinformatics companies could consolidate data, make analysis & useful management and disseminate tools to help drug companies to curtail cost and time.

Given the said market structure there is an emerging need to develop breakthrough drugs while shortening the discovery time and costs. There is also need for forming mergers and partnerships of companies both at local and international levels. Leading biotech firms like Compugen, DoubleTwist have come forward with novel drug programs. Interestingly, India and South East Asian countries have comparative advantage in terms of cheap labor, which can offer database solutions and genome research for biotech companies globally.

“World Bioinformatics Market (2005-2010)” gives an overview of the bioinformatics market segments and that they are poised for future growth. The market research report also elicits the unusual, critical and outstanding opportunities for expansion in the next five years itself.

REPORT HIGHLIGHTS

The market research report particularly interested in the value added by bioinformatics to the process of drug discovery and development discuss various technologies and patenting trends in the industry.

This new market research report provides you with the most detailed and up-to-date analysis, news, developments, experts’ opinions and insight into the informatics market. The report includes chapters that provide:

- Detailed analysis of the latest trends in bioinformatics.
- In-depth profiles of 26 leading companies with informatics tools and technologies and its 5-year forecasts for the year 2005-2010.
- Survey of industry experts’ views on informatics.
- Potential of bio-informatics applications and market predictions of trends in US expenditure on IT solutions.
- Projections for future applications in drug discovery, R&D and analysis of commercial business strategies.
- Latest developments and comprehensive insight into bioinformatics business strategies.

The aim of this study was to analyze the possible growth opportunities for the bioinformatics industry. We are also interested in determining the current models employed for commercialization of bioinformatics and to examine the success of such models.

REPORT FEATURES
The market research report “World Bio-Informatics Market (2005-2010)” compiles a study of economic environment, technological descriptions and bioinformatics applications which would be valuable for investors and companies engaged in gene therapy and molecular medicine. It essentially aims the pharmaceutical industry, biotechnology firms, research laboratories and those interested in the commercial opportunities in this field.

The report compiles eight chapters where chapters 2 & 3 give introduction to bioinformatics and, rules and regulations framework of the industry respectively. Chapter 4 covers the bioinformatics market of 2005 by Geographical segmentation and Application areas. Chapter 5 provides the nanotechnology aspect of bioinformatics industry; chapter 6 gives the market opportunities and challenges; chapter 7 gives product innovations and launches like Super Server, Experiment Design Automation, new tools for genomic and proteomic research, Sigma-Aldrich launches, Ciphergen’s new Equalizer technology and so on. Finally Chapter 8 gives company profiles of key players.

Contents:

1. Executive Summary

2. Introduction to Bioinformatics
2.1. Applications of Bio-Informatics

3. Rules and Regulations Framework of the Bioinformatics Industry
3.1. Privacy
3.2. Intellectual Property
3.3. Open Source
3.4. Additional Legal Concerns
3.5. Issues Related to Bio-Informatics Transactions

4. Global Bioinformatics Industry—Technology and Market Analysis, 2005
4.1. Total Bioinformatics Market ($ Million), 2005
4.2. Bio-Informatics Market, By Geographical Segmentation, (%) 2005
4.2.1 US and Canada
4.2.2 Europe
4.2.3 Asia-Pacific
4.3. Bioinformatics Market, By Application Areas, (%) 2005
4.3.1 Pharmacogenomics
4.3.2 Proteomics
4.3.3 Genomics
4.3.4 Drug Discovery
4.4. Bioinformatics Market, By IT Tools, (%) 2005
4.5. Investment Opportunities from Biotech Companies and Venture Capitalists (%), 2005
4.6. Employment Opportunities (%), 2005
4.7. Future Forecast of Bioinformatics Market, 2010

5. Nanotechnology in Bioinformatics Industry

6. Market Opportunities and Challenges for Bioinformatics

7. Product Innovations and Launches
7.1. Super Server for Bioinformatics Developed
7.2. GeneDirector® and GeneSight® Achieves GeneChip-compatible™ Status
7.3. Benchware Notebook and Benchware Dock Launched for Real-Time Virtual-Screening Analyses
7.4. SYBYL Molecular Modeling Suite 7.1 Version Released — Includes Innovative New Products and Numerous Enhancements
7.5. Deployment of Industry-Leading Enterprise Chemical Informatics System at Schering AG
7.6. Open Integration Platform Launched by Accelrys technology to Enable Customers to Construct Tailored Solutions
7.7. SciTegic Launches New Sequence Analysis Collection
7.8. TCS Develops Bioinformatics Software on Linux Platform
7.9. Rosetta Biosoftware and Agendia to Deliver Diagnostic Utilities
7.10. Gene-IT Unveils Sequence-Centric Data Integration Approach to Overcome Challenges of Genome-Scale Research
7.11. Sigma-Aldrich Launches Functional Cancer Protein Microarray
7.12. Ciphergens New Equalizer(TM) Technology Enables the Detection of Low Abundance Proteins

8. Company Profiles
8.1. Accelrys Inc.
8.2. ACLARA BioSciences Inc.
8.3. Ariadne Genomics
8.4. Affymetrix
8.5. Agilent Technologies Inc.
8.6. Amersham Biosciences Limited
8.7. Applied Biosystems Group
8.8. BioDiscovery Inc.
8.9. Celera Genomics Corporation
8.10. Cengent Therapeutics Inc.
8.11. Ciphergen Biosystems Inc.
8.12. Compugen Limited
8.13. CuraGen Corporation
8.14. Gene Logic
8.15. GeneMachines Inc.
8.16. Geospiza
8.17. IBM Life Sciences
8.18. Illumina Inc.
8.19. InforMax Inc.
8.20. Incyte Corporation
8.21. Lion Bioscience AG
8.22. Silicon Graphics Inc.
8.23. Spotfire Incorporation
8.24. Tripos Inc.
8.25. Xanthon Inc.
8.26. Zyomyx Inc.

List of Tables
Table 8-1: Accelrys Inc.
Financial Statistics (2003-2005)
Table 8-2: ACLARA BioSciences, Inc.
Financial Statistics (2002-2004)
Table 8-3: Affymetrix
Financial Statistics (2002-2004)
Table 8-4: Agilent Technologies Inc.
Financial Statistics (2002-2004)
Table 8-5: Amersham Biosciences Limited
Financial Statistics (2002 & 2003)
Table 8-6: Applied Biosystems Group
Financial Statistics (2003-2005)
Table 8-7: Ciphergen Biosystems Inc.
Financial Statistics (2002-2004)
Table 8-8: CuraGen Corporation
Financial Statistics (2002-2004)
Table 8-9: Gene Logic
Financial Statistics (2002-2004)
Table 8-10: Illumina Inc.
Financial Statistics (2002-2004)
Table 8-11: InforMax Inc.
Financial Statistics (2001 & 2002)
Table 8-12: Incyte Corporation
Financial Statistics (2002-2004)
Table 8-13: Lion Bioscience AG
Financial Statistics, 2005
Table 8-14: Silicon Graphics, Inc.
Financial Statistics (2003-2005)
Table 8-15: Tripos Inc.
Financial Statistics (2002-2004)

List of Figures
Figure 4-1: Worldwide Value of Bioinformatics Market ($ Million), 2002-2005
Figure 4-2: US
Bioinformatics Market ($ Million), 2002-2005
Figure 4-3: US
Funding for the Microbial Genome Project ($ Million), 1997-2004
Figure 4-4: Europe
Bio-Informatics Market ($ Million), 2002-2005
Figure 4-5: Europe
Total Research and Development Funding and Drugs in Pipeline, By Company Size (%), 2004
Figure 4-6: Asia Pacific
Bioinformatics Market ($ Million), 2002-2005
Figure 4-7: Worldwide Pharmacogenomics Market (%), 2008
Figure 4-8: Worldwide DNA Sequencing and Proteomics Market ($ Billion), 2004-2009
Figure 4-9: Worldwide Genomics Market ($ Billion), 2002-2005
Figure 4-10: Worldwide Drug Discovery Expenditure ($ Billion), 2002 & 2006
Figure 4-11: Revenues for Selected Drug Discovery related Products ($ Million), 2000 & 2005
Figure 4-12: Investment Trends in IT Tools in Bio-Informatics Industry ($ Billion), 2005 & 2010
Figure 4-13: Worldwide Market of IT Tool Suppliers and Providers in Bioinformatics (%), 2005
Figure 4-14: Worldwide Market of Servers, Storage Devices & Services (US $ Million), 2000-2004
Figure 4-15: Biotech Companies Investment Ratio (%)
Figure 4-16: Venture Capitalist Investment Ratio in Bioinformatics (%)
Figure 4-17: World Bioinformatics Market by Geographical Segmentation (%), 2010
Figure 4-18: Revenue Share of Analysis Software and Services Segment in Bioinformatics ($ Billion), 2005 & 2010
Figure 5-1: Global Market For Nanotechnology Applications in the Bioinformatics ($ Billion), 2005 & 2010
Figure 5-2: Market Share of Nanotechnology in Bio-Informatics by NanoComponents (%), 2004

Summary:

REPORT HIGHLIGHTS:
The market research report particularly interested in the value added by bioinformatics to the process of drug discovery and development discuss various technologies and patenting trends in the industry.

This new market research report provides you with the most detailed and up-to-date analysis, news, developments, experts' opinions and insight into the informatics market. The report includes chapters that provide:
1. Detailed analysis of the latest trends in bioinformatics.
2. In-depth profiles of 26 leading companies with informatics tools and technologies and its 5-year forecasts for the year 2005-2010.
3. Survey of industry experts' views on informatics.
4. Potential of bio-informatics applications and market predictions of trends in US expenditure on IT solutions.
5. Projections for future applications in drug discovery, R&D and analysis of commercial business strategies.
6. Latest developments and comprehensive insight into bioinformatics business strategies.

The aim of this study was to analyze the possible growth opportunities for the bioinformatics industry. We are also interested in determining the current models employed for commercialization of bioinformatics and to examine the success of such models.

REPORT FEATURES/ WHO SHOULD BUY THIS?
The market research report "World Bio-Informatics Market (2005-2010)" compiles a study of economic environment, technological descriptions and bioinformatics applications which would be valuable for investors and companies engaged in gene therapy and molecular medicine. It essentially aims the pharmaceutical industry, biotechnology firms, research laboratories and those interested in the commercial opportunities in this field.

The report compiles nine chapters where chapters 2 & 3 give introduction to bioinformatics and, rules and regulations framework of the industry respectively. Chapter 4 deals with the global bioinformatics industry as per technology and market analysis of 2005. Chapter 5 provides the nanotechnology aspect of bioinformatics industry; chapter 6 gives the market opportunities and challenges; chapter 7 gives product innovations and launches like Super Server, Experiment Design Automation, new tools for genomic and proteomic research, SYBYL Molecular Modeling Suite 7.1, Open Integration Platform, SciTegic launches, TCS Bioinformatics software, Rosetta Biosoftware, Sigma-Aldrich launches, Ciphergen's new Equalizer technology and so on. Chapter 8 talks about recent issues and current developments. Finally chapter 9 gives company profiles of key players.

Companies Mentioned

Accelrys Inc. ACLARA BioSciences Inc. Ariadne Genomics Affymetrix Agilent Technologies Inc. Amersham Biosciences Limited Applied Biosystems Group BioDiscovery Inc. Celera Genomics Corporation Cengent Therapeutics Inc. Ciphergen Biosystems Inc. Compugen Limited CuraGen Corporation Gene Logic GeneMachines Inc. Geospiza IBM Life Sciences Illumina Inc. InforMax Inc. Incyte Corporation Lion Bioscience AG Silicon Graphics Inc. Spotfire Incorporation Tripos Inc. Xanthon Inc. Zyomyx Inc.

Ordering:

Order Online - visit http://www.researchandmarkets.com/reports/310170

Order by Fax - using the order form below

Order By Post - print the order form below and send to

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.